← The FDA Ephemeris: the whole map
Kisunla donanemab-azbt
Queued: 18 FDA documents (1,372 pages) are in the system, waiting to be read into the graph.
- Application
- BLA 761248
- Sponsor
- Eli Lilly
- Drug class
- Anti-amyloid antibody
- First approved
- January 18, 2023
FDA decisions
Also anti-amyloid antibodys: Aduhelm, Leqembi, Leqembi Iqlik
From FDA documents. Not medical advice.